Dr. Reddy's Laboratories

Pfizer

Bioaccelerate Holdings

Laboratory Corp. of America

Dainippon Pharmaceutical

Advanced Biological Laboratories SA (ABL, S.A) Licenses Stanford HIV Resistance Interpretation Algorithm - Adds to Viroscore Suite Genetic Sequence Database and Analysis Engine

ABL to integrate the Stanford Algorithm with the 5 algorithms currently used in its "global resistance interpretation" report offered in the ViroScore Suite Diagnostic Product.

ABL, SA (A Luxembourg Company) with TherapyEdge Inc. (Durham, NC) today announced it had signed a license agreement to use the Stanford University HIVdb resistance interpretation algorithm in their ViroScorer Report.